Back to dashboard
CommercialCoverageMedium impact

08.02.36a, Zolbetuximab-clzb (Vyloy®)

Independence Blue Cross·Oncology, Gastroenterology·Pharmacy
Effective date
Apr 29, 2026
We identified it
Jun 19, 2026
Days to comply
—

Summary

A new policy for Zolbetuximab-clzb (Vyloy®) has been issued for commercial insurance plans. This appears to be a pharmacy policy update that will become effective on April 29, 2026, indicating coverage decisions or billing guidelines for this newly approved medication.

Action Required

Action needed
Before April 29, 2026: Review the full policy document at the provided URL to understand specific coverage criteria, prior authorization requirements, and billing guidelines for Zolbetuximab-clzb (Vyloy®). Update pharmacy benefit management systems and provider education materials accordingly for commercial plans.

Related policy hubs